Where does Optibiotix Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Optibiotix Limited ranks #27,045 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Optibiotix Limited hold?

Optibiotix Limited holds 10 US utility patents granted between 2018 and 2025, spanning 11 technology areas.

What is Optibiotix Limited's Innovation Score?

Optibiotix Limited has an Innovation Score of 31.9 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Optibiotix Limited focus on?

Optibiotix Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 9 patents, ranking #2,057 of 6,058 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

Is Optibiotix Limited's patent grant rate increasing or decreasing?

Optibiotix Limited's recent grant velocity is +250% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Optibiotix Limited's patents?

Optibiotix Limited's patents average 13.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Optibiotix Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Optibiotix Limited

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Optibiotix ranks #27,045 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#27,045
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.9/100): 13.1
avg claims per patent: +250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27045 · Foreign Corporation #27,045 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,045/49,997
PHOTO-FINISH One Home Brands
CPC-FOCUS A61P · 11 areas
INNOV-THIN 31.9/100
CLAIMS-RICH 13.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +250% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: One Home Brands, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Optibiotix’s 31.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (26%) Velocity 4.0 pts (13%) Breadth 11.7 pts (37%) Claim depth 7.9 pts (25%)

Qualcomm Incorporated · highest

85
Optibiotix · this assignee

32
3D Lighting… · lowest

7

What this shows Optibiotix's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Optibiotix?

Each dot is one of Optibiotix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Optibiotix’s own 13.1 claims/patent is at or below the 14.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Optibiotix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Optibiotix's grants concentrate

Optibiotix Limited is a focused PatentsView assignee: 11 CPC subclasses with 90% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2018. By volume, Optibiotix sits between One Home Brands, Inc. and Oxford Instruments AFM Inc.

Optibiotix's three-year grant acceleration

Optibiotix Limited shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

One Home Brands

10
One Lambda

10
One Star Internat…

10
Opla Energy

10
Orlandi

10
Out of Sight Visi…

10
Oxford Biomedica…

10
Oxford Instrument…

10
Optibiotix ◀

10

What this shows Optibiotix holds 10 patents at rank #27,051, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Optibiotix

By rank, the assignees closest to #27,051 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Optibiotix's primary technology class.

Optibiotix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Optibiotix Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	10.0%
2019	1	10.0%
2020	2	20.0%
2021	2	20.0%
2023	1	10.0%
2024	2	20.0%
2025partial year	1	10.0%

Which technologies does Optibiotix Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 9

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 2

C12Y - Enzymes 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Optibiotix Limited's patent record in context - here's where to go next.

Optibiotix Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 90% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #27,045 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Optibiotix Limited against One Home Brands, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.